These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 26275084)

  • 21. Endoluminal resection for sessile neoplasia in the GI tract is associated with a low recurrence rate and a high 5-year survival rate.
    Wang AY; Ahmad NA; Zaidman JS; Brensinger CM; Lewis JD; Long WB; Kochman ML; Ginsberg GG
    Gastrointest Endosc; 2008 Jul; 68(1):160-9. PubMed ID: 18577483
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Laparoscopic Surgery In The Treatment of Gastrointestinal Stromal Tumors.
    Matlok M; Stanek M; Pedziwiatr M; Major P; Kulawik J; Budzynski P
    Scand J Surg; 2015 Sep; 104(3):185-90. PubMed ID: 25452425
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Prognosis analysis of 247 cases of gastrointestinal stromal tumor].
    Ning L; Zhang DF; Zhou YB; Jiao XL; Cao SG
    Zhonghua Wei Chang Wai Ke Za Zhi; 2013 Mar; 16(3):247-50. PubMed ID: 23536345
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Stromal gastrointestinal tumors: retrospective study of 24 cases].
    Boudabous H; Chaker Y; Nouira R; Dziri C
    Tunis Med; 2013 Nov; 91(11):661-7. PubMed ID: 24343490
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Audit of a series of 40 gastrointestinal stromal tumour cases.
    Hinz S; Pauser U; Egberts JH; Schafmayer C; Tepel J; Fändrich F
    Eur J Surg Oncol; 2006 Dec; 32(10):1125-9. PubMed ID: 16859873
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Surgically managed gastrointestinal stromal tumors: a comparative and prognostic analysis.
    Hassan I; You YN; Shyyan R; Dozois EJ; Smyrk TC; Okuno SH; Schleck CD; Hodge DO; Donohue JH
    Ann Surg Oncol; 2008 Jan; 15(1):52-9. PubMed ID: 18000711
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Surgical resection of gastrointestinal stromal tumors after treatment with imatinib.
    Andtbacka RH; Ng CS; Scaife CL; Cormier JN; Hunt KK; Pisters PW; Pollock RE; Benjamin RS; Burgess MA; Chen LL; Trent J; Patel SR; Raymond K; Feig BW
    Ann Surg Oncol; 2007 Jan; 14(1):14-24. PubMed ID: 17072676
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-term follow-up of patients with GIST undergoing metastasectomy in the era of imatinib -- analysis of prognostic factors (EORTC-STBSG collaborative study).
    Bauer S; Rutkowski P; Hohenberger P; Miceli R; Fumagalli E; Siedlecki JA; Nguyen BP; Kerst M; Fiore M; Nyckowski P; Hoiczyk M; Cats A; Casali PG; Treckmann J; van Coevorden F; Gronchi A
    Eur J Surg Oncol; 2014 Apr; 40(4):412-9. PubMed ID: 24491288
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic Factors of Patients with Gastric Gastrointestinal Stromal Tumor after Curative Resection: A Retrospective Analysis of 406 Consecutive Cases in a Multicenter Study.
    Kim IH; Kwak SG; Chae HD
    Eur Surg Res; 2015; 55(1-2):12-23. PubMed ID: 25766570
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Liver surgery in the multidisciplinary management of gastrointestinal stromal tumour.
    Cananzi FC; Belgaumkar AP; Lorenzi B; Mudan S
    ANZ J Surg; 2014 Dec; 84(12):E1-8. PubMed ID: 23647808
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Genomic Grade Assay Compared With Ki67 to Determine Risk of Distant Breast Cancer Recurrence.
    Ignatiadis M; Azim HA; Desmedt C; Veys I; Larsimont D; Salgado R; Lyng MB; Viale G; Leyland-Jones B; Giobbie-Hurder A; Kammler R; Dell'Orto P; Rothé F; Laïos I; Ditzel HJ; Regan MM; Piccart M; Michiels S; Sotiriou C
    JAMA Oncol; 2016 Feb; 2(2):217-24. PubMed ID: 26633571
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Risk of recurrence of gastrointestinal stromal tumour after surgery: an analysis of pooled population-based cohorts.
    Joensuu H; Vehtari A; Riihimäki J; Nishida T; Steigen SE; Brabec P; Plank L; Nilsson B; Cirilli C; Braconi C; Bordoni A; Magnusson MK; Linke Z; Sufliarsky J; Federico M; Jonasson JG; Dei Tos AP; Rutkowski P
    Lancet Oncol; 2012 Mar; 13(3):265-74. PubMed ID: 22153892
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Surgical treatment of locally advanced, non-metastatic, gastrointestinal stromal tumours after treatment with imatinib.
    Tielen R; Verhoef C; van Coevorden F; Gelderblom H; Sleijfer S; Hartgrink HH; Bonenkamp JJ; van der Graaf WT; de Wilt JH
    Eur J Surg Oncol; 2013 Feb; 39(2):150-5. PubMed ID: 23084087
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Liver surgery in the multidisciplinary management of gastrointestinal stromal tumour.
    Cananzi FC; Belgaumkar A; Lorenzi B; Mudan S
    ANZ J Surg; 2014 Dec; 84(12):937-42. PubMed ID: 25444423
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Microscopic margins of resection influence primary gastrointestinal stromal tumor survival.
    Catena F; Di Battista M; Ansaloni L; Pantaleo M; Fusaroli P; Di Scioscio V; Santini D; Nannini M; Saponara M; Ponti G; Persiani R; Delrio P; Coccolini F; Di Saverio S; Biasco G; Lazzareschi D; Pinna A;
    Onkologie; 2012; 35(11):645-8. PubMed ID: 23147540
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic factors in gastrointestinal stromal tumors: multicenter experience of 333 cases from Turkey.
    Seker M; Sevinc A; Yildiz R; Cihan S; Kaplan MA; Gokdurnali A; Dane F; Yaman E; Karaca H; Colak D; Uyeturk U; Bilici A; Ozdemir NY; Kalender ME; Uncu D; Salepci T; Isikdogan A; Benekli M; Ozkan M; Gumus M; Coskun U; Camci C; Oksuzoglu B; Buyukberber S;
    Hepatogastroenterology; 2013 Jun; 60(124):768-75. PubMed ID: 23165188
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Multivisceral resections for gastrointestinal stromal tumors: are the risks justifiable?
    Racz JM; Sunil S; Abramowitz D; Brar SS; Jimenez MC; Azin A; Atenafu EG; Jackson TD; Okrainec A; Quereshy FA
    Surg Oncol; 2015 Mar; 24(1):54-9. PubMed ID: 25697716
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Surgery including liver resection for metastatic gastrointestinal stromal tumors or gastrointestinal leiomyosarcomas.
    Nunobe S; Sano T; Shimada K; Sakamoto Y; Kosuge T
    Jpn J Clin Oncol; 2005 Jun; 35(6):338-41. PubMed ID: 15928191
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-term follow-up outcome of imatinib mesylate treatment for recurrent and unresectable gastrointestinal stromal tumors.
    Saito S; Nakata K; Kajiura S; Ando T; Hosokawa A; Sugiyama T
    Digestion; 2013; 87(1):47-52. PubMed ID: 23343969
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Exon 11 mutations, Ki67, and p16(INK4A) as predictors of prognosis in patients with GIST.
    Cerski MR; Pereira F; Matte US; Oliveira FH; Crusius FL; Waengertner LE; Osvaldt A; Fornari F; Meurer L
    Pathol Res Pract; 2011 Nov; 207(11):701-6. PubMed ID: 22024151
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.